Stock AMEU.F ANTERIS TECHNOLOGIES LTD
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Anteris Technologies Ltd OTC Markets

Equities

AMEU.F

AU0000088841

Market Closed - OTC Markets
Other stock markets
 09:30:03 2024-06-11 am EDT 		5-day change 1st Jan Change
12.95 USD +2.17% Intraday chart for Anteris Technologies Ltd 0.00% -1.89%
Jun. 13 Anteris Provides Update on DurAVR THV Valve-In-Valve Experience Presented at New York Valves 2024 CI
Jun. 11 Anteris Technologies Ltd Provides Data Update on First in Human Study of DurAVR THV Presented At New York Valves 2024 CI

Summary

  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • Over the past year, analysts have regularly revised upwards their sales forecast for the company.
  • Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • The company has insufficient levels of profitability.
  • One of the major weak points of the company is its financial situation.
  • Based on current prices, the company has particularly high valuation levels.
  • The company appears highly valued given the size of its balance sheet.
  • For the past year, analysts have significantly revised downwards their profit estimates.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
ANTERIS TECHNOLOGIES LTD Stock Anteris Technologies Ltd
-1.89% 235M -
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.60% 181B
C+
MEDTRONIC PLC Stock Medtronic plc
-4.45% 101B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.15% 67.54B
A
DEXCOM, INC. Stock DexCom, Inc.
-8.63% 45.09B
B-
CENCORA, INC. Stock Cencora, Inc.
+9.70% 44.37B
B-
HOYA CORPORATION Stock Hoya Corporation
+6.13% 40.7B
B+
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+15.22% 29.85B
B
TERUMO CORPORATION Stock Terumo Corporation
+14.80% 24.49B
A-
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-6.46% 23.99B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
-

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. AVR Stock
  4. AMEU.F Stock
  5. Ratings Anteris Technologies Ltd